期刊
CLINICAL MICROBIOLOGY AND INFECTION
卷 20, 期 -, 页码 66-75出版社
ELSEVIER SCI LTD
DOI: 10.1111/1469-0691.12570
关键词
Biomarker; vaccine; Staphylococcus aureus; outcome; review; protective immunity
资金
- National Institutes of Health [2R01-AI068804, UMI-AI104681]
In this review, we examine the current status of Staphylococcus aureus vaccine development and the prospects for future vaccines. Examination of the clinical trials to date show that murine models have not predicted success in humans for active or passive immunization. A key factor in the failure to develop a vaccine to prevent S.aureus infections comes from our relatively limited knowledge of human protective immunity. More recent reports on the elements of the human immune response to staphylococci are analysed. In addition, there is some controversy concerning the role of antibodies for protecting humans, and these data are reviewed. From a review of the current state of understanding of staphylococcal immunity, a working model is proposed. Some new work has provided some initial candidate biomarker(s) to predict outcomes of invasive infections and to predict the efficacy of antibiotic therapy in humans. We conclude by looking to the future through the perspective of lessons gleaned from the clinical vaccine trials.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据